Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 17, 2015
Grant Date -
Oct 15, 2015
app pub date -
Mar 11, 2014
filing date -
Feb 26, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides polynucleotides and polypeptides encoded therefrom having advantageous properties, including an ability to induce an immune response to flaviviruses. The polypeptides and polynucleotides of the invention are useful in methods of inducing immune response against flaviviruses, including dengue viruses. Compositions and methods for utilizing polynucleotides and polypeptides of the invention are also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully